Skip to content
buyWeak

Kevin C Tang bought $548k of TCRR

owner at TCR2 THERAPEUTICS INC.. 289,577 shares at an average of $1.89, traded May 3, 2023, filed May 5, 2023.

Conviction score
39
Value
$548k
289,577 shares
Holdings after
4,215,864
+7% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $548k at market
    +19
  • Relative to holdings
    Holdings up 7%
    +3
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Median 6-month excess return +10% over 4 past buys
    +10
  • Outside holder
    A 10% owner who is not an officer or director
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001209191-23-027833, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 3, 2023POpen-market purchase
Common Stockindirect: By LP
+18,513$1.85$34k3,944,800May 5, 2023
May 4, 2023POpen-market purchase
Common Stockindirect: By LP
+104,241$1.86$194k4,049,041May 5, 2023
May 5, 2023POpen-market purchase
Common Stockindirect: By LP
+95,759$1.90$182k4,144,800May 5, 2023
May 5, 2023POpen-market purchase
Common Stockindirect: By LP
+71,064$1.94$138k4,215,864May 5, 2023

Related signals

Other insiders at TCR2 THERAPEUTICS INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
31Weak
TCRRbuy
TCR2 THERAPEUTICS INC.
Kevin C Tang
owner
$86k
50,000 shares
+1%
36Weak
TCRRsell 2
TCR2 THERAPEUTICS INC.
Mpm Asset Management LLC
owner
$132k
70,170 shares
-19%
39Weak
TCRRsell 2
TCR2 THERAPEUTICS INC.
Ansbert Gadicke
director, owner
$132k
70,170 shares
-19%
31Weak
TCRRbuy
TCR2 THERAPEUTICS INC.
Kevin C Tang
owner
$88k
44,948 shares
+1%
33Weak
TCRRbuy
TCR2 THERAPEUTICS INC.
Kevin C Tang
owner
$164k
83,988 shares
+2%
15Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
Alfonso Quintas Cardama
Chief Medical Officer
$15k
13,799 shares
-11%
15Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
Angela Justice
Chief People Officer
$9,448
8,620 shares
-15%
31Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
Garry E Menzel
President and CEO
$35k
31,938 shares
-19%
15Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
Peter Olagunju
Chief Technical Officer
$5,299
4,830 shares
-17%
10Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
Alfonso Quintas Cardama
Chief Medical Officer
$10k
7,942 shares
-6%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kevin C Tang bought $548k of TCRR | InsiderTell